Skip to content
SOCI - Standing Committee

Social Affairs, Science and Technology

 

The Health of Canadians – The Federal Role

Final Report

Volume Six: Recommendations for Reform


APPENDIX A

List of Recommendations by Chapter

The Committee recommends that:

CHAPTER ONE:
The Need for an Annual Report on the State of the Health Care System and the Health Status of Canadians

A National Health Care Commissioner and National Health Care Council

New federal/provincial/territorial committee made up of five provincial/territorial and five federal representatives be struck. Its mandate would be to appoint a National Health Care Commissioner and the other eight members of a National Health Care Council from among the Commissioner’s nominees;

The National Health Care Commissioner be charged with the following responsibilities:

§   To put nominations for members to a National Health Care Council before the F/P/T committee and to chair the Council once the nominees have been ratified;

§   To oversee the production of an annual report on the state of the health care system and the health status of Canadians. The report would include findings and recommendations on improving health care delivery and health outcomes in Canada, as well as on how the federal government should allocate new money raised to reform and renew the health care system;

§   To work with the National Health Care Council to advise the federal government on how it should allocate new money raised to reform and renew the health care system in the ways recommended in this report;

§   To hire such staff as is necessary to accomplish this objective and to work closely with existing independent bodies to minimize duplication of functions.

The federal government provide $10 million annually for the work of the National Health Care Commissioner and the National Health Care Council that relates to producing an annual report on the state of the health care system and the health status of Canadians, and to advising the federal government on the allocation of new money raised to reform and renew the health care system.


CHAPTER TWO:
Hospital Restructuring and Funding in Canada

Service Based Funding 

Hospitals should be funded under a service-based remuneration scheme. This method of funding is particularly well suited for community hospitals located in large urban centres. In order to achieve this, a number of steps must be undertaken:

§   A sufficient number of hospitals should be required to submit information on case rates and costing data to the Canadian Institute for Health Information;

§   The Canadian Institute for Health Information, in collaboration with the provinces and territories, should establish a detailed set of case rates to reduce incentives to up-code.

§   The federal government should devote ongoing funding to the Canadian Institute for Health Information for the purpose of collecting and estimating the data needed to establish service-based funding.

§   The shift to service-based funding should occur as quickly as possible. The Committee considers a five-year period to be a reasonable timeframe for the full implementation of the new hospital funding.

Service-based funding should be augmented by an additional funding method that would take into account the unique services provided by Academic Health Sciences Centres, including teaching and research.

In developing a service-based remuneration scheme for financing of community hospitals, consideration be given to the following factors:

§   Isolation: hospitals located in rural and remote areas are expected to incur higher costs than those in large urban centres. An adjustment should reflect this fact.

§   Size: small hospitals are expected to incur higher costs per weighted case than larger hospitals. An adjustment should recognize this fact.

 

Capital Support for Hospitals 

The federal government provide capital financial support for the expansion of hospitals located in areas of exceptionally high population growth; that is, areas in which the population growth exceeds the average rate of growth in the province by 50% or more. Such federal financial support should account for 50% of the total capital investment needed. In total, the federal government should devote $1.5 billion to this initiative over a 10-year period, or $150 million annually.

The federal government should encourage the provinces and territories to explore public-private partnerships as a means of obtaining additional investment in hospital capacity.

The federal government contribute $4 billion over the next 10 years (or $400 million annually) to Academic Health Sciences Centres for the purpose of capital investment.

Academic Health Sciences Centres be required to report on their use of this federal funding.

 

CHAPTER THREE

Devolving Further Responsibility to Regional Health Authorities

Regional health authorities in major urban centres be given control over the cost of physician services in addition to their responsibility for hospital services in their regions. Authority for prescription drug spending should also be devolved to RHAs.

Regional health authorities should be able to choose between providers (individual or institutional) on the basis of quality and costs, and to reward the best providers with increased volume.  As such, RHAs should establish clear contracts specifying volume of services and performance targets.

The federal government should encourage the devolution of responsibility from provincial/territorial governments to regional health authorities, and participate in evaluating the impact of internal market reforms undertaken at the regional level.

 

CHAPTER FOUR

Primary Health Care Reform

The federal government continue to work with the provinces and territories to reform primary care delivery, and that it provide ongoing financial support for reform initiatives that lead to the creation of multi-disciplinary primary health care teams that:

§   are working to provide a broad range of services, 24 hours a day, 7 days a week;

§   strive to ensure that services are delivered by the most appropriately qualified health care professional;

§   utilise to the fullest the skills and competencies of a diversity of health care professionals;

§   adopt alternative methods of funding to fee-for-service, such as capitation, either exclusively or as part of blended funding formulae;

§   seek to integrate health promotion and illness prevention strategies in their day-to-day work;

§   progressively assume a greater degree of responsibility for all the health and wellness needs of the population they serve.

The federal government commit $50 million per year of the new revenue the Committee has recommended it raise to assist the provinces in setting up primary care groups.

 

CHAPTER FIVE

Timely Access to Health Care

There are no recommendations in this chapter.

 

CHAPTER SIX

The Health Care Guarantee

For each type of major procedure or treatment, a maximum needs-based waiting time be established and made public.

When this maximum time is reached, the insurer (government) pay for the patient to seek the procedure or treatment immediately in another jurisdiction, including, if necessary, another country (e.g., the United States).  This is called the Health Care Guarantee.

The process to establish standard definitions for waiting times be national in scope.

An independent body be created to consider the relevant scientific and clinical evidence.

Standard definitions focus on four key waiting periods – waiting time for primary health care consultation; waiting time for initial specialist consultation; waiting time for diagnostic tests; waiting time for surgery.

 

CHAPTER SEVEN

Expanding Coverage to Include Protection Against Catastrophic Prescription Drug Costs

The federal government introduce a program to protect Canadians against catastrophic prescription drug expenses.

For all eligible plans, the federal government would agree to pay:

§   90% of all prescription drug expenses over $5,000 for those individuals for whom the combined total of their out-of-pocket expenses and the contribution that a province/territory incurs on their behalf exceeds $5000 in a single year;

§   90% of prescription drug expenses in excess of $5,000 for individual private supplementary prescription drug insurance plan members for whom the combined total of their out-of-pocket expenses and the contribution that the private insurance plan incurs on their behalf exceeds $5,000 in a single year.

§   the remaining 10 % would be paid by either a provincial/territorial plan or a private supplementary plan.

In order to be eligible to participate in this federal program: 

§   provinces/territories would have to put in place a program that would ensure that no family of the province/territory would be obliged to pay more than 3% of family income for prescription drugs;

§   sponsors of existing private supplementary drug insurance plans would have to guarantee that no individual plan member would be obliged to incur out-of-pocket expenses that exceed $1,500 per year; this would cap each individual plan member’s out-of-pocket costs at either 3% of family income or $1,500, whichever is less.

The federal government work closely with the provinces and territories to establish a single national drug formulary.

 

CHAPTER EIGHT

Expanding Coverage To Include Post-Acute Home Care (PAHC)

When Does PAHC Coverage Begin and End

An episode of PAHC should be defined as all home care services received between the first date of service provision following hospital discharge, if that date occurs within 30 days of discharge, and up to three months following hospital discharge.

PAHC Financing Directed to Hospitals

Financing for post-acute home care should be first directed to hospitals.

In order to encourage innovation and service integration, and to enhance the efficient and effective provision of necessary health care irrespective of the setting in which such care is received, a service-based method of reimbursement for PAHC should be developed in conjunction with service-based arrangements for each episode of hospital care.

Range of Services Covered

The range of services, products and technologies (including prescription drugs) that may be used to facilitate the use of home care following hospital care not be restricted.

 

PAHC Funded Through Service Based Funding 

Hospitals have the option to develop contractual relationships directly with home care service providers or with transfer agencies that may provide case management and service provision arrangements.

Contracts formed with home care service providers should include, in addition to service-based reimbursement arrangements, mechanisms to monitor service quality, performance and outcome.

 

PAHC Programs Should Be Cost-Shared

The federal government establish a new National Post-Acute Home Care Program, to be jointly financed with the provinces and territories on a 50:50 basis.

The PAHC program be treated as an extension of medically necessary coverage already provided under the Canada Health Act, and that therefore the full cost of the program should be borne by government (shared equally by the provincial/territorial and federal levels).

 

CHAPTER NINE

Expanding Coverage to Include Palliative Home Care

The federal government agree to contribute $250 million per year towards a National Palliative Home Care Program to be designed with the provinces and territories and co-funded by them on a 50:50 basis.

The federal government examine the feasibility of allowing Employment Insurance benefits to be provided for a period of six weeks to employed Canadians who choose to take leave to provide palliative care services to a dying relative at home.

The federal government examine the feasibility of expanding the tax measures already available to people providing care to dying family members or to those who purchase such services on their behalf.

The federal government amend the Canada Labour Code to allow employee leave for family crisis situations, such as care of a dying family member, and that the federal government work with the provinces to encourage similar changes to provincial labour codes.

The federal government take a leadership role as an employer and enact changes to Treasury Board legislation to ensure job protection for its own employees caring for a dying family member.

 

CHAPTER TEN

The Federal Role in Health Care Infrastructure

Health Care Technology 

The federal government provide funding to hospitals for the express purpose of purchasing and assessing health care technology.  The federal government should devote a total of $2.5 billion over a five-year period (or $500 million annually) to this initiative.  Of this funding, $400 million should be allocated annually to Academic Health Sciences Centres, while $100 million should be provided annually to community hospitals.  The community hospital funding should be cost-shared on a fifty-fifty basis with the provinces, while the Academic Health Sciences Centre funding should be 100% federal.

The institutions benefiting from this program be required to report on their use of such funding.

 

Electronic Health Records

The federal government provide additional financial support to Canada Health Infoway Inc. so that Infoway develop, in collaboration with the provinces and territories, a national system of electronic health records.

Additional federal funding to Infoway amount to $2 billion over a five-year period, or an annual allocation of $400 million.

 

Evaluation of System Performance 

The federal government provide additional annual funding of $50 million to the Canadian Institute for Health Information. In addition, an annual investment of $10 million should be provided to the Canadian Council on Health Services Accreditation. This new federal investment will help establish a national system of evaluation of health care system performance and outcomes, and hence facilitate the work of the National Health Care Commissioner.

Protection of Personal Health Information 

The federal government work to achieve greater consistency and/or coordination across federal/provincial/territorial jurisdictions on the following key issues:

§   Need-to-know rules restricting access to authorized users based on their purposes;

§   Consent rules governing the form and criteria of consent in order to be valid;

§   Conditions authorizing non-consensual access to personal health information in limited circumstances and for specific purposes;

§   Rules governing the retention and destruction of personal health information;

§   Mechanisms for ensuring proper oversight of cross-jurisdictional electronic health record systems.

Canada Health Infoway Inc. and other key investors structure their investment criteria in such a way as to create incentives for developers of EHR systems to ensure practical and pragmatic privacy solutions for implementing the following:

§   State-of-the-art security safeguards for protecting personal health information and auditing transactions;

§   Shared accountability among various custodians accessing and using EHRs;

§   Coordination among custodians to give meaningful effect to patients’ rights to access their EHR, rectify any inaccuracy and challenge non-compliance.

Key stakeholders, including the federal, provincial and territorial Ministries of Health, Canada Health Infoway Inc., the Canadian Institute for Health Information and Canadian Institutes of Health Research, undertake the following:

§   Rigorous research into the determinants affecting Canadian attitudes regarding acceptable and unacceptable uses of their personal health information;

§   Informed and meaningful dialogue with key stakeholders, including patient groups and consumer representatives;

§   An open, transparent and iterative public communication strategy about the benefits of EHRs.

 

CHAPTER ELEVEN

Health Care Human Resources

The Need for Productivity Studies

Studies be done to determine how the productivity of health care professionals can be improved. These studies should be either undertaken or commissioned by the National Coordinating Committee on Health Human Resources that the Committee recommends be created.

The National Coordinating Committee for Health Human Resources 

The federal government work with other concerned parties to create a permanent National Coordinating Committee for Health Human Resources, to be composed of representatives of key stakeholder groups and of the different levels of government. Its mandate would include:

§   disseminating up-to-date data on human resource needs;

§   coordinating initiatives to ensure that adequate numbers of graduates are being trained to meet the goal of self-sufficiency in health human resources;

§   sharing and promoting best practices with regard to strategies for retaining skilled health care professionals and coordinating efforts to repatriate Canadian health care professionals who have emigrated to other countries;

§   recommending strategies for increasing the supply of health care professionals from under-represented groups, such as Canada’s Aboriginal peoples, and in under-serviced regions, particularly the rural and remote areas of the country;

§   examining the possibilities for greater coordination of licensing and immigration requirements between the various levels of government.

 

Increasing the Supply of Health Human Resources 

The federal government:

§   Work with provincial governments to ensure that all medical schools and schools of nursing receive the funding increments required to permit necessary enrolment expansion;

§   Put in place mechanisms by which direct federal funding could be provided to support expanded enrolment in medical and nursing education, and ensure the stability of funding for the training and education of allied health professionals;

§   Review federal student loan programs available to health care professionals and make modifications to ensure that the impact of inevitable increases in tuition fees does not lead to denial of opportunity to students in lower socio-economic circumstances;

§   Work with provincial governments to ensure that the relative wage levels paid to different categories of health professionals reflect the real level of education and training required of them.

The federal government work with the provinces and medical and nursing faculties to finance places for students from Aboriginal backgrounds over and above those available to the general population.

In order to facilitate the return to Canada of Canadian health care professionals who are working abroad, the federal government should work with the provinces and professional associations to inform expatriate Canadian health professionals of emerging job opportunities in Canada, and explore the possibility of adopting short-term tax incentives for those prepared to return to Canada.

The federal government contribute $160 million per year, starting immediately, so that Canadian medical colleges can enrol 2,500 first-year students by 2005.

The proposed National Coordinating Committee for Health Human Resources be charged with monitoring the levels of enrolment in Canadian medical schools and make recommendations to the federal government on whether these are appropriate.

The federal government should contribute financially to increasing the number of post-graduate residency positions in medicine to a ratio of 120 per 100 graduates of Canadian medical schools.

The federal government work with the provinces to establish national standards for the evaluation of international medical graduates, and provide ongoing funding to implement an accelerated program for the licensing of qualified IMGs and their full integration into the Canadian health care delivery system.

The federal government phase in funding over the next five years so that by 2008 there are 12,000 graduates from nursing programs across the country, and that the federal government continue to provide full additional funding to the provinces for all nursing school places over and above 10,000, for as long as is necessary to eliminate the shortage of nurses in the country.

The federal government commit $90 million per year from the additional revenue the Committee recommends that it raise in order to enable Canadian nursing schools to graduate 12,000 nurses by 2008.

The federal government commit $40 million per year from the new revenues that the Committee has recommended it raise in order to assist the provinces in raising the number of allied health professionals who graduate each year.

The exact allocation of these funds be determined by the proposed National Coordinating Committee for Health Human Resources.

The federal government devote $75 million per year of the new money the Committee recommends be raised to assisting Academic Health Sciences Centres to pay the costs associated with expanding the number of training slots for the full range of health care professionals.

Review Scope of Practice Rules

An independent review of scope of practice rules and other regulations affecting what individual health professionals can and cannot do be undertaken for the purpose of developing proposals that would enable the skills and competencies of diverse health care professionals to be utilized to the fullest and enable health care services to be delivered by the most appropriately qualified professionals.


CHAPTER TWELVE

Nurturing Excellence in  Canadian Health Research

Assuming Leadership in Health Research

Health research and its translation into the health care system be routinely on the agendas of meetings of federal and provincial/territorial Ministers and Deputy Ministers of Health, and that the Canadian Institute of Health Research be represented and be involved in setting the agendas for health research at those meetings. This would greatly help to sustain a culture that supports the creation and use of knowledge generated by health research throughout Canada.

The federal government set, on a regular basis, national goals and priorities for health research in collaboration with all stakeholders.

The federal government foster multi-stakeholder collaborations when performing, funding and using health research. This should contribute to capitalizing on the best available resources while minimizing overlap and duplication.

The federal government take a leadership role, through the Canadian Institutes of Health Research and Health Canada, in developing a strategy to encourage the interchange of research scientists between government, academia and the private sector, including national voluntary organizations.

Funding Health Research

The federal government, through both Health Canada and the Canadian Institutes of Health Research, coordinate and provide resources to ensure that Canada contributes to and benefits from the scientific revolution to maximize the economic, health and social gains for Canadians.

The Canadian Institutes of Health Research and Genome Canada fund research that positions Canada as a world leader in the new area of genomics and human genetics so that the health care system can take appropriate advantage of this new technology to improve the health of Canadians.

The Canadian Institutes of Health Research play a leadership role in establishing best practices for addressing the complex ethical issues raised by the use of this new technology in health research and health care.

The federal government:

§   Increase, within a reasonable timeframe, its financial contribution to extramural health research to achieve the level of 1% of total Canadian health care spending.  This requires an additional investment of $440 million by the federal government;

§   Recognize that health research is a long term proposition, and therefore set and adhere to clear long-term plans for funding health research, particularly through the Canadian Institutes of Health Research.  More precisely, the federal government should commit to a five-year planning horizon for the CIHR budget;

§   Provide predictable and appropriate investment for in-house health research.

 

Health Canada:

§   Be provided with the financial and human resources in health research that are required to fulfill its mandate and obligations;

§   Engage actively in the establishment of linkages and partnerships with other health research stakeholders.

The federal government, through the Canadian Institutes of Health Research, Health Canada and the Canadian Health Services Research Foundation, devote additional funding to health services research and clinical research and that it collaborate with the provinces and territories to ensure that the outcomes of such research are broadly diffused to health care providers, managers and policy-makers.

Health Research on Vulnerable Populations

The federal government, through the Canadian Institutes of Health Research and Health Canada, provide additional funding to health research aimed at the health of particularly vulnerable segments of Canadian society.

The federal government provide additional funding to CIHR in order to increase participation of Canadian health researchers, including Aboriginal peoples themselves, in research that will improve the health of Aboriginal Canadians.

Health Canada be provided with additional resources to expand its research capacity and to strengthen its research translation capacity in the field of Aboriginal health.

The federal government provide increased resources to the Global Health Research Initiative.

Commercializing the Results of Health Research 

The federal government require an explicit commitment from all recipients of federally funded health research that they will obtain the greatest possible benefit to Canada, whenever the results of their federally funded research are used for commercial gain.

The Canadian Institutes of Health Research, while not ignoring the social value of health research that does not result in commercial gain, seek to facilitate appropriate economic returns within Canada from the investments it makes in Canadian health research, whenever the results of investments in Canadian health research are used for commercial gain.  In doing so, CIHR should develop an innovation strategy aimed at accelerating and facilitating the commercialization of health research outcomes.

The federal government invest additional resources to enhance the output of Canadian health researchers and strengthen the commercialization capacity of performers of federally funded health research through CIHR’s innovation strategy.  This new funding would be additional to the current health research investment.  In particular, the funding of the indirect costs of research by the Canadian granting agencies should be made permanent.  Health research performers should be made accountable for the use of these commercialization funds.

Ethics in Health Research 

Health Canada initiate, in collaboration with stakeholders, the development of a joint governance system for health research involving human subjects for all research that the federal government performs, that it funds, and that it uses in its regulatory activities.

Health Canada, in the development of this ethics governance system, regard the following components as essential to progress:

§   Work initially on all (health) research that the federal government performs, funds, or uses in its regulatory activities, to develop an effective and efficient system of governance that will become accepted as the standard of care across Canada;

§   Give prime importance in the governance system to effective education and training mechanisms for all who are involved in research and research ethics, with certification appropriate to their different responsibilities;

§   Develop standards, based on the Tri-Council Policy Statement, the International Conference on Harmonization guidelines applying to clinical trials involving human subjects, and other relevant Canadian and foreign standards, against which research ethics functions or Research Ethics Boards can be accredited or certified as meeting the levels of function that are consistent with the expectations of Canadians and with those in other countries;

§   Ensure that the Tri-Council Policy Statement is updated and is maintained at the forefront of international policies for the ethics or research involving humans;

§   Remove inconsistencies between the various policies under which research involving humans is now governed, and make Canadian standards consistent with those of other countries that affect Canadian research;

§   Establish an accreditation or certification process for research ethics functions that is at arm’s length from government, but clearly accountable to government;

§   Develop the governance system through open, transparent and meaningful consultation with stakeholders.

All federal departments and agencies require compliance with the standards of the Canadian Council on Animal Care for:

§   All research that is carried out in federal facilities, and

§   All research that is funded by federal departments or agencies but performed outside federal facilities, and

§   All research that is carried out without federal funding or facilities, but that is submitted to or used by the federal government for purposes of exercising its legislated functions.

 

The Protection of Personal Health Information 

Regulations such as those proposed by the Canadian Institutes of Health Research receive their fullest and fairest consideration in discussions about providing greater clarity and certainty of the law with the view to ensure that its objectives will be met without preventing important research to continue to better the health of Canadians and improve their health services.

Discussions continue among stakeholders, the Privacy Commissioner, and those federal and provincial government departments involved with the provision, management, evaluation and quality assurance of health services.

The federal government, through the Canadian Institutes of Health Research and Health Canada, together with other relevant stakeholders, design and implement a program of public awareness to foster in Canadians a broad understanding of:

§   the nature of, and reasons for, the extensive databases containing personal health information that must be maintained to operate a publicly financed health care system, and

§   the critical need to make secondary use of such databases for health research and health care management purposes.

The federal government, through the Canadian Institutes of Health Research and Health Canada, together with other relevant stakeholders, be responsible for promoting:

§   thoughtful discussion and consideration of the ethical issues, particularly informed consent issues, involved in the secondary use of personal health information for health care management and health research purposes;

§   thorough examination of the control and review mechanisms needed for ensuring that databases containing personal health information are effectively created, maintained and safeguarded and that their use for health care management and health research purposes is conducted in an open, transparent and accountable manner.

The Canadian Institutes of Health Research, in partnership with industry and other stakeholders, continue to explore the ethical aspects of the interface between the sectors with a view to ensuring that the collaborations and partnerships function in the best interests of all Canadians.


CHAPTER THIRTEEN

Healthy Public Policy: Health Beyond Health Care

National Chronic Disease Prevention Strategies 

The federal government, in collaboration with the provinces and territories and in consultation with major stakeholders (including the Chronic Disease Prevention Alliance of Canada), implement a National Chronic Disease Prevention Strategy.

The National Chronic Disease Prevention Strategy build on current initiatives through better integration and coordination.

The federal government contribute $125 million annually to the National Chronic Disease Prevention Strategy.

Specific goals and objectives should be set under the National Chronic Disease Prevention Strategy. The outcomes of the strategy should be evaluated against these goals and objectives on a regular basis.

 

Public Health Infrastructure  

The federal government ensure strong leadership and provide additional funding to sustain, better coordinate and integrate the public health infrastructure in Canada as well as relevant health promotion efforts.  An amount of $200 million in additional federal funding should be devoted to this very important undertaking.

 

CHAPTER FOURTEEN

How the New Federal Funding  for Health Care Should Be Managed

The federal government establish an Earmarked Fund for Health Care that is distinct and separate from the Consolidated Revenue Fund.  The Earmarked Fund will contain the additional revenue raised by the federal government for investment in health care.

Money from the Earmarked Fund for Health Care be used solely for the purpose of health care.  Moreover, such money must be used to buy change or reform: it must be utilized exclusively for expanding public health care coverage and for restructuring and renewal of the publicly funded hospital and doctor system.

The National Health Care Council be charged with the mandate of advising the federal government on how the money in the Earmarked Fund for Health Care should be spent. The Council’s advice to the government should be made public through an annual report.

The federal government subject the Earmarked Fund for Health Care to an annual audit by the Auditor General of Canada. The result of such an audit should be made public.

The federal government require the provinces and territories to report annually to the Canadian public on their utilization of federal money from the Earmarked Fund for Health Care.

CHAPTER FIFTEEN

How Additional Federal Funds for  Health Care Should Be Raised

Funding the Recommendations in this Report

The federal government establish a National Variable Health Care Insurance Premium in order to raise the necessary federal revenue to finance implementation of the Committee’s recommendations.

Funding Current Federal Expenditures on Health Care 

The federal government determine an earmarked revenue source which would fund the approximately 62% of CHST currently regarded as being the federal annual cash contribution to Canada’s national health care insurance program.

If the GST is chosen as the earmarked revenue source for the current federal cash contribution to the national hospital and doctor insurance plan, then in order for the federal government to make a significant additional contribution to funding to the current hospital and doctor system, half of all GST revenue (or 3.5 of the 7 percentage points) should be earmarked for health care. (This would be in addition to the increased federal funding required to implement the recommendations in this report.)

The share of the federal annual contribution to which a province/territory is entitled for the purpose of the existing national hospital and doctor program be not only based on the proportion of its population relative to Canada as a whole, but also weighted in some way by the percentage of its population aged 70 years and over.

 

CHAPTER SIXTEEN

The Consequences of Not Making the Health Care System Fiscally Sustainable

There are no recommendations in this chapter.

 

CHAPTER SEVENTEEN

The Canada Health Act

The federal government, in collaboration with the provinces and territories, establish a permanent committee – the Committee on Public Health Care Insurance Coverage – made up of citizens, ethicists, health care providers and scientists.

The Committee on Public Health Care Insurance Coverage be given the mandate to review and make recommendations on the set of services that should be covered under public health care insurance.

The Committee on Public Health Care Insurance Coverage report its findings and recommendations to the National Health Care Council.

As its first task, the Committee on Public Health Care Insurance Coverage be charged with developing national standards upon which decisions for public health care coverage will be made.

The Committee on Public Health Care Insurance Coverage be charged with determining the national parameters applicable to post-hospital home care and palliative care delivered in the home.

The federal government enact new legislation establishing the National Health Care Guarantee. The new legislation should include a definition of the concept of “timely access” that will relate to such a guarantee.

The principle of public administration of the Canada Health Act be maintained for publicly insured hospital and doctor services. That is, there should be a single insurer – the government – for publicly insured hospital and doctor services delivered by either public or private health care providers and institutions.

The federal government, through Health Canada, clarify the meaning of the concept of public administration under the Canada Health Act so as to recognize explicitly that this principle applies to the administration of public health care insurance, not to the delivery of publicly insured health services.

The federal government enact new legislation instituting health care coverage for catastrophic prescription drugs, post-hospital home care and some palliative care in the home. This new legislation should explicitly spell out conditions relating to transparency of decision making and accountability.


APPENDIX B

List of Principles from Volume Five (April 2002)

The following principles, enunciated in Volume Five, have guided the Committee in developing the detailed plan of action outlined in this report.

THE INSURER:

1.      There should be a single funder (insurer) – the government either directly or through an arm’s length agency – for hospital and doctor services covered under the Canada Health Act.

2.      There should be stability of, and predictability in, government funding for public health care insurance.

3.      The federal government should play a major role in sustaining a national health care insurance system.

4.      The determination of what should be covered under public health care insurance should be done through an open and transparent process. Health services covered under the Canada Health Act should remain publicly insured.  Other health services should continue to be funded using a mix of public and private sources, as they are now. 

5.      The federal government should contribute on an ongoing basis to fund health care technology.

6.      The federal government should increase its investment in those areas of health and health care for which it already has a major responsibility.

7.      The consequences arising from changes in the level or amount of government funding for hospital and medical care should be clearly understood by government and explained to the public, in as much detail as possible, at the time such changes are made and announced.


THE PROVIDER:

8.      In the first stage of health care reform, the method for remunerating hospitals should be changed from the current annual global budget to service-based funding.

9.      Regional health authorities should have the responsibility for purchasing hospital services provided by institutions within their region.

10.  Primary care renewal should lead to the provision of primary care by group practices, or clinics, which operate twenty-four hours a day, seven days a week.

11.  To facilitate primary care reform, the method of compensating general practitioners should be changed from fee-for-service to some form of blended remuneration combining capitation, fee-for-service and other incentives or rewards.

12.  New scope of practice rules and other measures need to be developed in order to enable all health care providers in the primary care sector to provide the full range of services for which they have been trained.

13.  In the second stage of health care reform, an “internal market” should probably be created in which primary health care teams would purchase health services provided by hospitals and other health care institutions on behalf of their patients.

14.  A national (not exclusively federal) strategy must be developed to achieve both an adequate supply and optimal use of health care providers.

 

THE EVALUATOR:

15.  Accountability and transparency in health care financing and delivery require the deployment of a system of electronic health records (EHR) that can capture and translate information on system performance and outcomes.

16.  Measuring treatment outcomes and system performance must become an essential part of the health information system.  Such monitoring and evaluation of the health care delivery system should be performed independently at the national (not federal) level and be funded by government.


THE PATIENT:

17.  Canada’s publicly funded health care system should be patient-oriented.

18.  Incentives should be developed to encourage patients to use the hospital and doctor system as efficiently as possible.  Such incentives should not include user fees for services that are deemed to be medically necessary.

19.  Programs that enable people to be responsible for their own health and to stay healthy must be given high priority.  The federal government can play a leadership role in this regard.

20.  For each type of major procedure or treatment a maximum waiting time should be established, and made public.  When this maximum time is reached, the insurer (government) shall pay for the patient to receive immediately the procedure or treatment in another jurisdiction including, if necessary, another country


APPENDIX C

List of Witnesses

1st Session of the 37th Parliament 

Wednesday, April 24, 2002 

Ontario Health Services Restructuring Commission:
Dr. Duncan Sinclair, Former Commissioner

 

Thursday, April 25, 2002 

Health Canada:
Marcel Nouvet, Assistant Deputy Minister, Information Analysis and Connectivity Branch
Michel Léger, Executive Director, Strategic Alliances and Priorities Division, Information Analysis and Connectivity Branch

 

Wednesday, May 1, 2002 

Canadian Institute for Health Information:
Michael Decter, Chairman, Board of Directors

 

Monday, May 6, 2002 

Calgary Health Region:
Jack Davis, President and CEO

As an individual:
Claude Forget, Former Minister of Health, Province of Quebec

Dalhousie University:
Dr. Nuala Kenny, Professor of Pediatrics and Chair, Department of Bioethics 

St. Michael’s  Hospital:
Jeffrey Lozon, President and CEO 

As an individual:
Graham Scott, Former Deputy Minister of Health, Province of Ontario 

Royal Columbian Hospital:
Dr. Les Vertesi, Medical Director

 

Wednesday, May 8, 2002 

As an individual:
The Honourable Monique Bégin, P.C. 


Thursday, May 9, 2002

Dalhousie University:
Professor Lawrence Nestman, School of Health Services Administration


Wednesday, May 22, 2002 

Canadian Medical Association:
Dr. Peter Barrett, Past President
Dr. Susan Hutchison, Chair, GP Forum 

Ontario Medical Associaiton:
Dr. Elliot Halparin, President
Dr. Kenneth Sky, Past President 

Ontario Hospital Association:
Mark Rochon, Member, Advocacy Committee 

Association of Canadian Academic Health Care Organizations:
Glenn G. Brimacombe, CEO 

University Health Network:
Kevin Empey, Chief Financial Officer 

 

Wednesday, May 29, 2002  

Capital Health Authority:
Dr. Ken Gardener, Vice-President, Medical Affairs

Ontario Family Health Network:
Dr. Ruth Wilson, Chair
Donna Segal, CEO

 

Thursday, May 30, 2002  

McMaster University – Centre for Health Economics and Policy Analysis (CHEPA):
Dr. Brian Hutchison

University of Guelph:
Professor Brian Ferguson, Department of Economics 

 

Monday, June 3, 2002  

University of Toronto, Department of Health Policy, Management and Evaluation:
Professor Raisa Deber 

University of British Columbia:
Professor Roberts G. Evans 

Canadian Taxpayers Federation:
Walter Robinson, Federal Director 

The Conference Board of Canada:
Paul Darby, Director, Economic Forecasting 

As an individual:
David Kelly 

 

Wednesday, June 5, 2002

Canadian Healthcare Association:
Sharon Sholzberg-Gray, President and CEO
Larry Odegard, CEO, Forum 

Canadian Association of Chain Drug Stores:
Lori Turik, Vice-President, Public Affairs
Deb Saltmarche, Director of Pharmacy 

 

Thursday, June 6, 2002

Canadian Nurses Association:
Ginette Lemire Rodger, President
Robert Calnan, President-Elect 

Canadian Practical Nurses Association:
Kelly Kay, Representative 

 

Wednesday, June 12, 2002

C.D. Howe Institute:
Jack Mintz, President and CEO

 

Thursday, June 13, 2002

Association of Canadian Academic Health Care Organizations:
Glenn Brimacombe, CEO 

St.Michael’s Hospital:
Jeffrey Lozon, President and CEO 

McGill University Health Centre:
Dr. Hugh Scott, Executive Director 

Applied Management:
Bryan Ferguson, Partner  

Fraser Group:
Ken Fraser 

Tristat Resources:
Richard Shillington, Principal

 

Monday, June 17, 2002 (9:00 a.m.) 

(By videoconference)
Government of Denmark:
John Erik Petersen, Head of Department, Ministry of Health and the Interior
Dr. Steen Friberg Nielsen, CEO, Top Management Academy
Morten Hjulsager, Head of Department, National Informatics, National Board of Health
Dr. Arne Kverneland, Head of Division of Medical Informatics, National Board of Health

 

Monday, June 17, 2002 (12:30 p.m.) 

Government of New Brunswick, Department of Health and Wellness:
Cheryl Hansen, Director, Extra-Mural Program 

University of Toronto, Home Care Evaluation Research Centre:
Peter Coyte, Co-Director 

Hollander Analytical Services:
Marcus Hollander 

Canadian Council of Chief Executives:
David Stewart-Patterson, Senior Vice President, Policy 

VOLUME FIVE (October 15, 2001 - March 7, 2002)

Monday, October 15, 2001

University of Manitoba:
Linda West, Professor, Asper School of Business

Frontier Centre for Public Policy:
Peter Holle, President

Western Canadian Task Force on Health Research and Economic Development:
Dr. Henry Friesen, Team Leader
Dr. John Foerster
Dr. Audrey Tingle
Chuck Laflèche

Regional Health Authorities of Manitoba
Bill Bryant, Chair, Council of Chairs
Kevin Beresford, Chair, Council of CEOs
Randy Lock, Executive Director

Manitoba Centre for Health Policy and Evaluation:
Dr. Nora Lou Roos

Women's Health Clinic:
Madeline Boscoe, Advocacy Coordinator

Hospice and Palliative Care Manitoba:
Dr. Paul Henteleff, Chair, Advocacy Committee
John Bond, Member of Advocacy Committee
Margaret Clarke, Executive Director

Canadian Union of Public Employees in Manitoba (CUPE):
Paul Moist, President
Lorraine Sigurdson, Health Care Coordinator

Société franco-manitobaine:
Daniel Boucher, Chief Executive Officer

As a walk-on:
Barry Shtatleman


Tuesday, October 16, 2001

Saskatchewan Registered Nurses' Association:
June Blau, President

Victorian Order of Nurses:
Bob Layne, Vice-President, Planning and Government Relations (Western Region)
Lois Clark, Executive Director, VON North Central Saskatchewan
Brenda Smith, National Board Member (Saskatchewan)

Community Health Services (Saskatoon) Association:
Kathleen Storrie, Vice-President
Ingrid Larson, Director, Member Relations 

As an individual:
Dr. John Bury

Canadian Union of Public Employees (CUPE) Saskatchewan:
Tom Graham, President, CUPE Saskatchewan
Stephen Foley, President, Health Care Council
John Welden, Health Care Coordinator, Health Care Council

Saskatoon Chamber of Commerce:
Dave Ductchak, President
Kent Smith-Windsor, Executive Director
Jodi Blackwell, Research and Operations Director

Arthritis Society of Saskatchewan:
Sherry McKinnon, Executive Director
Joy Tappin, Board Member

Canadian Parks and Recreation:
Randy Goulden, Executive Director, Tourism Yorkton

Métis National Council:
Gerald Morin, President
Don Fidler, Director, Health Care


Wednesday, October 17, 2001

Premier's Advisory Council on Health (Alberta):
The Right Honourable Don Mazankowski, P.C., Chair
Peggy Garritty

Department of Health and Social Services (Nunavut):
The Hon. Edward Picco, Minister

Calgary Health Region:
Jack Davis, CEO

Capital Health Authority:
Sheila Weatherill, President and CEO

Canadian Practical Nurses Association:
Pat Fredrickson, President

University of Alberta - Faculty of Nursing:
Dr. Donna Wilson

Health Sciences Association of Alberta:
Elisabeth Ballermann, President

Alberta Association of Registered Nurses:
Sharon Richardson, President

United Nurses of Alberta:
Heather Smith, President

Friends of Medicare:
Christine Burdett, Provincial Chair
Tammy Horne, Member

As an individual:
Kevin Taft, MLA

Western Canada Waiting List Project:
John McGurran, Project Director

Primary Care Initiative:
Dr. June Bergman

Alberta Consumers Association:
Wendy Armstrong

Fédération des communautés francophones et acadiennes du Canada :
George Arès, President

National Advisory Council on Aging:
Pat Raymaker, Chairwoman

Alberta Council on Aging:
Neil Reimer, Secretary/Treasurer

Nechi Institute:
Ruth Morin, Chief Executive Officer
Richard Jenkins, Director of Marketing and Health Promotion

Executive of the Alberta and Northwest Conference of the United Church of Canada - Health Advisory Committee:
Louise Rogers
Kent Harold
Don Junk

As a walk-on:
Noel Somerville

Thursday, October 18, 2001

Commission on Medicare, Saskatchewan:
Ken Fyke, Former Chair

Tommy Douglas Research Institute:
Dave Barrett, Chair
Marc Eliesen, Co-Chair

Market-Media International Corporation:
Joan Gadsby, President

University of British Columbia, Family Practice Residency Program:
Dr. J. Galt Wilson, Program Director - Prince George Site

University of British Columbia:
Dr. John A. Cairns, Dean of Medicine
Dr. Joanna Bates, Associate Dean, Admissions

Health Professions Council:
Dianne Tingey, Member
Gerry Fahey, Research Director

Cambie Surgery Centre:
Dr. Brian Day, Founder

As an individual:
Cynthia Ramsay, Health Economist

Health Association of British Columbia:
Lorraine Grant, Chair of the Board of Directors
Lisa Kallstrom, Executive Director

University of British Columbia:
Dr. John H. V. Gilbert, Coordinator of Health Sciences

University of British Columbia - Vancouver Hospital and Health Sciences Centre:
Professor Charles Wright, Director, Centre for Clinical Epidemiology and Evaluation

University of British Columbia - Centre for Health Services and Policy Research:
Professor Barbara Mintzes

Professional Association of Residents of British Columbia:
Dr. Kristina Sharma

Friday, October 19, 2001

Canadian Medical Association:
Dr. Peter Barrett, Past President
Dr. Arun Garg, Chair, Council on Health Policy and Economics

British Columbia Medical Association:
Dr. Heidi Oetter, President
Darrell Thomson, Director, Economics and Policy Analysis

University of British Columbia, Anxiety Disorders Unit, Department of Psychiatry:
Dr. Peter D. McLean, Professor and Director

Maples Surgical Centre (Manitoba)
Dr. Mark Godley


Monday, October 29, 2001

Canadian Radiation Oncology Services:
Dr. Thomas McGowan, President and Medical Director

Canadian Taxpayers Federation:
Walter Robinson, Federal Director

Canadian Council of Churches:
Stephen Allen, Member of Commission for Justice and Peace and Co-Chair of the Commission's Ecumenical Health Care

Buffett Taylor Employee Benefits and Workplace Wellness Consultants:
Edward Buffett, President and CEO

As an individual:
Michael Rachlis

Medical Reform Group:
Dr. Joel Lexchin

At Work Health Solutions Inc.:
Dr. Arif Bhimji, Founder and President; Medical Director of Liberty Health
Gery Barry, President and CEO of Liberty Health

Consumers' Association of Canada:
Jean Jones, Chair of the Health Committee
Mel Fruitman, President

Ontario Association of Optometrists:
Dr. Joseph Chan

Medical Devices Canada (MEDEC):
Peter Goodhand, President

AstraZeneca:
Gerry McDole, President and CEO

Comcare Health Services:
Mary Jo Dunlop

Saint Michael's Hospital:
Jeffrey Lozon, President and CEO

Association of Ontario Health Centres:
Gary O'Connor, Executive Director

Ontario Medical Association:
Kenneth Sky, President

The Arthritis Society:
Denis Morrice, President and CEO

SMARTRISK:
Dr. Robert Conn, President and CEO


Canadian Cancer Society:
Dr. Barbara Whylie, Director, Cancer Control Policy
Cheryl Mayer, Director, Cancer Control Programs, Alcohol and Drug Recovery Association of Ontario, and Addiction Intervention Association
Jeff Wilbee, Executive Director

Tuesday, October 30, 2001

Canadian Institute for Health Information:
Michael Decter, Chairman, Board of Directors

Ontario Hospital Association:
David MacKinnon, President and CEO

Registered Nurses Association of Ontario:
Doris Grinspun, Executive Director

McMaster University Department of Economics:
Jeremiah Hurley, Professor

University of Toronto Public Health Science Department:
Dr. Cameron Mustard, Professor

University of Toronto:
Colleen Flood, Professor

Drug Trading Company Limited:
Larry Latowsky, President and CEO
Jane Farnharm, Vice President, Pharmacy

Canadian Pharmacists Association:
Ron Elliott, President

GlaxoSmithKline:
Geoffrey Mitchinson, Vice-president, Public Affairs

Medtronic:
Donald A. Hurley, President

Canadian Association for the Fifty Plus:
Dr. Bill Gleberzon, Associate Executive Director
Lilian Morgenthal, President

Canadian Association for Community: 
Cheryl Gulliver, President
Connie Laurin-Bowie
Margot Easton

Roeher Institute:
Cameron Crawford, President

As individuals:
Clement Edwin Babb
Robert S.W. Campbell


Wednesday, October 31, 2001

As individuals:
The Honourable Claude Forget
The Honourable Claude Castonguay
André-Pierre Contandriopoulos, Professor, Faculty of Medicine, University of Montreal

Hôtel Dieu Hospital:
Dr. Serge Boucher

Conseil du patronat du Québec:
Gilles Taillon, President

Canadian Chamber of Commerce:
Nancy Hughes-Anthony, President and Chief Executive Officer
Michael N. Murphy, Senior Vice-President, Policy

As individuals:
Jean-Luc Migué
Lee Soderstrom, Professor, Department of Economics, McGill University

Montreal Economic Institute:
Michel Kelly-Gagnon, Executive Director
Dr. Edwin Coffey, Retired Associate Professor, Faculty of Medicine, McGill University, and Former President of the Quebec Medical Association

Frosst Health Care Foundation:
Dr. Monique Camerlain, President of the Board of Directors
Janet Dunbrack, Executive Director.

Thursday, November 1, 2001

Association des optométrists du Québec:
Dr. Langis Michaud, President
Marie-Josée Crête, Deputy Director General
Clairmont Girard, Advisor

Collège des médécins du Québec:
Dr. Yves Lamontagne, President
Dr. André Garon, Deputy Secretary General

As an individual:
Robert Dorion

Canadian Life and Health Insurance Association:
Mark Daniels, President
Greg Traversy, Executive Vice-President
Yves Millette, Senior Vice-President, Quebec Affairs
Frank Fotia, Vice-President, Group Insurance.

As individuals:
Dr. Margaret Somerville, Acting Director, McGill Centre for Medicine, Ethics and Law, McGill University
Dr. Robyn Tamblyn, Associate Professor, Department of Economics, McGill University

Merck Frosst Canada Ltd.:
Kevin Skilton, Director, Policy Planning
Dr. Terrance Montague, Executive Director, Patient Health

Association québécoise des droits des retraités (AQDR):
Ann Gagnon, Advisor on Health
Yollande Richer, Vice-President, Communications
Myroslaw Smereka, Director General

Monday, November 5, 2001

Department of Health and Community Services, Newfoundland:
Robert C. Thompson, Deputy Minister 
Beverly Clarke, Assistant Deputy Minister

Victorian Order of Nurses (VON Canada):
Patricia Pilgrim, President, St. John's Branch
Bernice Blake Dibblee, Executive Director, St. John's Branch

Association of Registered Nurses of Newfoundland and Labrador:
Sharon Smith, President 

Canadian Union of Public Employees, Newfoundland:
Wayne Lucas, President

As an individual:
Maud Peach

National Cancer Institute of Canada:
Dr. Roy West, President

Health and Community Services, Newfoundland:
Dr. Catherine Donovan

Weight Watchers:
Marlene Bayers, Regional Manager

Newfoundland Cancer Treatment and Research Foundation:
Bertha H. Paulse, Chief Executive Officer 

As an individual:
Karen McGrath, Executive Director of Health and Community Services St. John's Region

Tuesday, November 6, 2001

Canadian Auto Workers (CAW):
Cecil Snow, President, Nova Scotia Health Care Council

Nova Scotia Association of Health Organizations:
Robert Cook, President and CEO

Insurance Bureau of Canada:
George Anderson, President and CEO
Paul Kovacs, Senior Vice-President, Policy, and Chief Economist 

Canadian Coalition Against Insurance Fraud:
Mary Lou O'Reilly, Executive Director

Atlantic Institute for Market Studies:
Dr. David Zitner, Fellow on Health Policy

Dalhousie University:
Nuala Kenny, Professor of Pediatrics and Chair, Department of Bioethics 
Dr. Vivek Kusumakar, Head, Mood Disorders Research Group, Department of Psychiatry
Lawrence Nestman, Professor, School of Health Services Administration

Nova Scotia Valley Caregivers Support Group:
Maxine Barrett

Elizabeth May Chair in Women's Health and the Environment, Dalhousie University:
Sharon Batt, Chair

Feminists for Just and Equitable Public Policy:
Ms. Georgia MacNeil, Chair Person

Cape Breton Regional Health Care Complex:
John Malcom, CEO
Dr. Mahmood Naqvi, Medical Director, Cape Breton Regional Facility

Capital District Health Authority: 
Dr. John Ruedy, Vice-President, Academic Affairs

Dalhousie University:
Thomas Rathwell, Professor and Director, School of Health Services Administration

Canadian Medical Association:
Dr. Henry Haddad, MD, President
Bill Tholl, Secretary General
Dr. Bruce Wright, President of the Medical Society of Nova Scotia
Dr. Dana W. Hanson, President-Elect

Dalhousie University:
Dr. Desmond Leddin, Head, Division of Gastroenterology
Dr. George Kephart, Director, Population Health Research Unit, Department of Community and Epidemiology
Dr. Kenneth Rockwood, Faculty of Medicine, Division of Geriatric Medicine

Cobequid Community Health Board:
Ryan Sommers

Health Canada:
Anne-Marie Leger, Policy Analyst

Wednesday, November 7, 2001

Department of Health and Social Services, Prince Edward Island:
The Honourable Jamie Ballem, Minister

PEI Seniors Advisory Council:
Heather Henry-MacDonald, Chair

Canadian Union of Public Employees, PEI Division:
Bill A. McKinnon, National Representative
Ms. Donalda MacDonald, President
Raymond Léger, Research Representative

Department of Health and Social Services:
Mary Hughes-Power, Director of Acute and Continuing Care
Deborah Bradley, Manager of Public Health Policy

College of Family Physicians of Canada:
Dr. Peter MacKean, Chairman of the Board

Queen Elizabeth Hospital:
Iain Smith, Drug Utilization Coordinator

PEI Pharmacy Board:
Neila Auld, Executive Director, PEI 

Queen's Regional Health Authority:
Sylvia Poirier, Chair

West Prince Regional Health Authority:
Ken Ezeard, Chief Executive Officer

Department of Health and Social Services:
Dr. Don Ling, Director of Medical Services

Department of Health and Social Services, Prince Edward island:
Rory Francis, Deputy Minister
Bill Harper, Assistant Deputy Minister
Jean Doherty, Communications Coordinator

Southern Kings Health Authority:
Betty Fraser, Chief Executive Officer

Department of Health and Social Services:
Susan Maynard, Senior Health Planner
Kathleen Flanagan-Rochon, Community Services Coordinator

Evangeline Health Centre:
Elise Arsenault, Coordinator 

East Prince Regional Health Authority:
David Riley, Chief Executive Officer

Dalhousie University:
Dr. Stan Kutcher, Department Head of the Community Health and Epidemiology/ Psychiatry

Thursday, November 8, 2001

Faculty of Nursing, University of New Brunswick:
Dr. Margaret Dykeman

New Brunswick Health Care Association:
Robert Simpson, Chief Executive Officer

Canadian Association of Chain Drug Stores:
Sherry Porter, Atlantic Canada Representative
Sandra Aylward, Vice President, Pharmacy Services


As individuals:
Dr. Russell King, Former Minister of Health, Province of New Brunswick
William Morrissey, Former Deputy Minister of Health, Province of New Brunswick

Applied Management:
Bryan Ferguson, Partner

Société des Acadiens et Acadiennes du Nouveau-Brunswick:
Daniel Thériault, Director General

Canadian Snowbird Association:
Bob Jackson, President

New Brunswick Senior Citizens Federation Inc.:
Helen Ladouceur, Member
Eilleen Malone, Member

Catholic Health Association of Canada:
Sandra Keon, Secretary Treasurer; and Vice-President of Clinical Programs, Pembroke Hospital

Miramichi Police Force:
Michael Gallagher, Corporal, Drug Section

Canadian Union of Public Employees, New Brunswick:
Raymond Léger, Research Representative

Federal Superannuates National Association:
Rex G. Guy, National President
Roger Heath, Research and Communications Officer

Union of New Brunswick Indians:
Nelson Solomon, Director of Health
Wanda Paul Rose, Coordinator
Norville Getty, Consultant

Nurses Association of New Brunswick:
Roxanne Tarjan, Director General

Thursday, February 21, 2002

Canadian Federation of Nurses Unions:
Kathleen Connors, President

Canadian Health Coalition:
Dr. Arnold Relman, Former editor of New England Journal of Medicine
Michael McBane, National Coordinator

Federal Superannuates National Co-ordinator:
Rex G. Guy, National President
Roger Heath, Research and Communications Officer


Thursday, March 7, 2002

Canadian Healthcare Association:
Sharon Sholzberg-Gray, President and CEO
Kathryn Tregunna, Director, Policy Development

Canadian Labour Congress:
Kenneth V. Georgetti, President
Cindy Wiggins, Senior Researcher, Social and Economic Policy Department

 

VOLUME THREE (May 28, 2001 - June 14, 2001)

Monday, May 28, 2001
(By videoconference)

From the Ministry of Health, Welfare and Sports of the Netherlands:
Dr. Hugo Hurts, Deputy Director, Health Insurance Division, Ministry of Health, Welfare and Sports of the Netherlands

From the International Institute of Social Studies of the Netherlands:
Professor James Bjorkman

Thursday, June 7, 2001 (9:00 a.m.)
(by videoconference)

Swedish Parliament (Riksdag):
Lars Elinderson, Deputy member, Committee on Health and Welfare

Monday, June 11, 2001
(By videoconference)

German Health Ministry:
Georg Baum, Director General, Head of Directorate Health Care
Dr. Margot Faelker, Deputy-Director, Section Financial Issues of Statutory Health Insurance
Dr. Rudolf Vollmer, Director-General, Head of Directorate Long-Term Nursing Care Insurance

Department of Health - Economic and Operational Research Division of the United Kingdon:
Clive Smee, Chief Economic Adviser

University of Birmingham:
Professor Chris Ham, Director, Health Services Management Centre

London School of Economics:
Professor Julien LeGrand, Richard Titmuss Professor of Social Policy, LSE Health & Social Care


Tuesday, June 12, 2001
(By videoconference)

Australian Institute of Health and Welfare:
Dr. Richard Madden, Director

Australian Health Insurance Association:
Russel Schneider, CEO

National Centre for Epidemiology and Population Health - Australian National University
Dr. Tony Adams, Professor of Public Health

Health Insurance Commission:
Dr. Brian Richards

Australian Medical Association:
Dr. Carmel Martin, Director
Dr. Roger Kilham


Wednesday, June 13, 2001

Health Canada:
Ake Blomqvist, Visiting Academic, Applied Research and Analysis Directorate, Information, Analysis and Connectivity Branch and Professor, University of Western Ontario

University of Calgary:
Professor Cam Donaldson, Department of Economics

University of Toronto (by videoconference):
Professor Colleen Flood, Faculty of Law

As an individual:
Claude Forget

University of Toronto:
Professor Mark Stabile, Department of Economics
Professor Carolyn Tuohy, Department of Political Science

Thursday, June 14, 2001
(by videoconference)

U.S. Department of Health and Human Services:
Christine Schmidt, Deputy to the Deputy Assistant Secretary for Health Policy, Office of the Assistant Secretary for Planning and Evaluation
Ariel Winter, Analyst
Tanya Alteras, Analyst

VOLUME TWO (March 21 2001 - June 7 2001)

Wednesday, March 21, 2001

Statistics Canada:
Réjean Lachapelle, Director, Demography Division
Jean-Marie Berthelot, Manager, Health Analysis and Modeling Group, Social and Economic Studies Division
Brian Murphy, Senior Research Analyst, Socio-Economic Modeling Group

Canadian Institute of Actuaries:
David Oakden, President
Rob Brown, Manager of Task Force on Health Care Financing
Daryl Leech, Chair, Committee on Health Care

National Advisory Council on Aging:

Dr. Michael Gordon, Member

Conference Board of Canada:
James G. Frank, Ph.D., Chief Economist and Vice-President
Glenn Brimacombe, Director of Health Program

Thursday, March 22, 2001

C.D. Howe Institute:
William B.P. Robson, Vice-President and Director of Research

McMaster University:
Byron G. Spencer, Professor

University of Ottawa:
Dr. William Dalziel


Wednesday, March 28, 2001

IMS Health Canada:
Dr. Roger A. Korman, President

Canadian Association of Pharmacists:
Dr. Jeff Poston, Executive Director

Health Promotion Research:
Dr. Robert Coambs, President and CEO

Health Canada:
Barbara Ouellet, Director of Home Care and Pharmaceuticals, Health Care Directorate, Policy and Consultation Branch

Thursday, March 29, 2001

Canadian Association of Radiologists:
Dr. John Radomsky

Thursday, March 29, 2001 (cont'd)

Canadian Coordinating Office for Health Technology Assessment (CCHOTA):
Dr. Jill Sanders, President and CEO

The Fraser Institute:
Martin Zelder, Director of Health Policy Research

As an individual:
Professor David Feeny


Wednesday, April 4, 2001

Health Canada:
Dr. Christina Mills, Director General, Centre for Chronic Disease Prevention and Control - Population Public Health Branch
Dr. Paul Gully, Acting Director General, Centre for Infectious Disease Prevention and Control
Dr. Clarence Clottey, Acting Director, Diabetes Division, Bureau of Cardio-Respiratory Diseases and Diabetes, Centre for Chronic Disease prevention and Control
Nancy Garrard, Director, Division of Aging and Seniors

Dalhousie University:
Dr. David MacLean, Departmental Head, Community Health and Epidemiology


Thursday, April 5, 2001

Health Canada:
Abby Hoffman, Director General, Health Care Directorate - Health Policy and Communications Branch
Cliff Halliwell, Director General, Applied Research & Analysis Directorate, Information, Analysis and Connectivity Branch
Nancy Garrard, Director, Division of Aging and Seniors


Thursday, April 26, 2001

Canadian Institute of Health Research:
Dr. Alan Bernstein, President

Health Canada:
Kimberly Elmslie, Acting Executive Director, Health Research Secretariat

Statistics Canada:
T. Scott Murray, Director General, Institutions and Social Statistics Branch


Wednesday, May 9, 2001

Canada's Research-Based Pharmaceutical Companies:
Murray Elston, President

Coalition for Biomedical and Health Research:
Dr. Barry McLennan, Chairman
Charles Pitts, Executive Director

Centre for Excellence for Women's Health:
Dr. Pat Armstrong

Canadian Genetic Diseases Network:
Dr. Ronald Worton, CEO & Scientific Director

Thursday, May 10, 2001

Health Canada:
William J. Pascal, Director General, Office of Health and Information Highway, Information, Analysis and Connectivity Branch

Canadian Institute for Health Information:
Dr. John S. Millar, Vice-President, Research and Analysis

Canadian Society of Telehealth:
Dr. Robert Filler, President

Department of Health and Wellness of New Brunswick
David Cowperthwaite, Director of Information System


Wednesday, May 16, 2001

Canadian Medical Association:
Dr. Peter Barrett, President

Canadian Medical Forum Task Force 1:
Dr. Hugh Scully, President

Federal Provincial Territorial Advisory Committee on Health Human Resources:
Dr. Thomas Ward, Chair

Canadian Nurses Association:
Sandra MacDonald-Remecz, Director of Policy, Regulation and Research

Canadian Federation of Nurses Unions:
Kathleen Connors, President

Ordre des infirmières et infirmiers auxiliaires du Québec:
Régis Paradis, President

Nurse Practitioners Association of Ontario:
Linda Jones

Canadian Radiation and Imaging Societies in Medicine (CRISM):
Dr. Paul C. Johns, Past Chair

The Canadian Chiropractic Association:
Dr. Tim St. Dennis, President

Canadian Society for Medical Laboratory Science:
Kurt Davis, Executive Director

Thursday, May 17, 2001

Canadian Home Care Association (CHCA):
Nadine Henningsen, Executive Director

Canadian Association for Community Care (CACC):
Dr. Taylor Alexander, President

Victorian Order of Nurses for Canada (VON Canada):
Diane McLeod, Vice-President, Policy, Planning and Government Relations, Central Region


Wednesday, May 30, 2001

Health Canada:
Ian Potter, Assistant Deputy Minister, First Nations and Inuit Health Branch
Jerome Berthelette, Special Advisor, Office of the Special Advisor Aboriginal Health, First Nations Inuit Health Branch
Dr. Peter Cooney, Acting Director General, Non-Insured Health Benefits, First Nations and Inuit Health

Indian and Northern Affairs Canada:
Chantal Bernier, Assistant Deputy Minister, Socio-economic Development Policy and Programs
Terry Harrison, Director, Social Services and Justice

Assembly of First Nations:
Elaine Johnston, Director of Health

Métis National Council:
Gerald Morin, President

Native Women's Association of Canada:
Michelle Audette, Interim Speaker and President of the Native Women Association of Quebec

Congress of Aboriginal Peoples:
Scott Clark, President, United Native Nations

Inuit Tapirisat of Canada:
Larry Gordon, Member ITC, Health Committee

Pauktuutit Inuit Women's Association:
Veronica N. Dewar, President

National Aboriginal Health Organization:
Dr. Judith Bartlett, Chair
Richard Jock, Executive Director

Canadian Institutes of Health Research:
Dr. Jeff Reading, Scientific Director, Institute of Aboriginal People's Health

Wikwemikong Health Centre:
Ron Wakegijig, Healer

National Indian and Inuit Community Health Representatives Organization:
Margaret Horn, Executive Director

Thursday, May 31, 2001

Health Canada:
Dr. John Wooton, Special Advisor on Rural Health, Population and Public Health Branch

Canadian Medical Association:
William Tholl, Secretary General and Chief Executive Officer

Society of Rural Physicians of Canada:
Dr. Peter-Hutten-Czapski, President

Consortium for Rural Health Research:
Dr. Judith Kulig


Wednesday, June 6, 2001

University of Ottawa:
Professor Martha Jackman, Faculty of Law

University of Calgary: (by videoconference)
Professor Sheilah Martin, Faculty of Law


Thursday, June 7, 2001 (11:00 a.m.)

Health Canada:
Nancy Garrard, Acting Director General, Centre for Healthy Human Development, Population and Public Health Branch
Tom Lips, Senior Policy Advisor for Mental Health, Population and Public Health Branch
Carl Lakaski, Senior Analyst, Mental Health, Health Human Resources Strategies Division, Health Policy and Communications Branch

Canadian Psychological Association:
Dr. John Service, Executive Director

Canadian Alliance on Mental Illness and Mental Health:
Phil Upshall, Coordinator

Canadian Mental Health Association:
Bonnie Pape

Department of Health and Wellness of New Brunswick:
Ken Ross, Assistant Deputy Minister, Mental Health Services

 

VOLUME ONE (March 2 200 - September 21, 2001)
(2nd Session, 36th Parliament)

Thursday, March 2, 2000

University of Toronto, Department of Health Administration:
Raisa Deber, Professor

Health Canada:
Dr. Robert McMurtry, G.D.W. Cameron Visiting Chair

Health Action Lobby (HEAL):
Sharon Sholzberg-Gray, Co-Chair

Dr. Mary Ellen Jeans, Co-Chair

Canadian Policy Research Network:
Sholom Glouberman, Director, Health Network

Wednesday, March 22, 2000

Founder's Network :
Dr. Fraser Mustard

Goldfarb Consultants:
Dr. Scott Evans, Senior Statistical Consultant

Environics Research Group :
Chris Baker, Vice-President

Health Canada:
Wendy Watson-Wright, Director General, Policy and Major Projects Directorate, Health Promotion and Programs Branch


Thursday, March 23, 2000

Health Canada:
Sylvain Paradis, Acting Policy Group Manager, Policy and Major Projects Directorate, Quantitative Analysis and Research Section, Health Promotion and Programs Branch
Liz Kusey, Policy Analyst, Policy and Major Projects Directorate, Health Promotion and Programs Branch
Monique Charon, Acting Director, Program Policy and Planning, Program Policy, Transfer Secretariat and Planning Directorate, Medical Services Branch
Mary Johnston, Education Consultant, Strategic Policy and Systems Coordination Section, Childhood and Youth Division - Health Promotion and Programs Branch
Julie MacKenzie, Senior Research Analyst, Strategic Policy and Systems Coordination Section, Childhood and Youth Division - Health Promotion and Programs Branch

Queens University - School of Policy Studies:
Keith Banting, Director

Thursday, April 6, 2000

University of British Columbia:
Robert G. Evans, Director, Population Health Program

Canadian Centre for Policy Alternatives:
Colleen Fuller

The Fraser Institute:
Martin Zelder, Director of Health Policy Research

Wednesday, May 3, 2000

Health Canada:
Cliff Halliwell, Director General, Applied Research & Analysis Directorate, Information, Analysis and Connectivity Branch
Abby Hoffman, Senior Policy Advisor
Frank Fedyk, Acting Director, Canada Health Act Directorate, Policy and Consultation Branch

Thursday, May 4, 2000

As an individual:
Tom Kent

University of Toronto:
Michael Bliss, Professor

Wednesday, May 10, 2000

University of Western Ontario:
Ake Blomqvist, Professor

University of Toronto:
Colleen Flood, Professor
Mark Stabile, Professor


Thursday, May 11, 2000

Canadian Institute for Health Information:
John S. Millar, Vice-President, Research and Analysis

McGill University:
Margaret Somerville, Professor

Alberta University:
Laura Shanner, Professor

Wednesday, May 17, 2000

As an individual:
The Honourable Marc Lalonde, P.C.

Wednesday, May 31, 2000

As an individual:
The Honourable Monique Bégin, P.C.

Wednesday, June 7, 2000

Department of Finance:
Guillaume Bissonnette, General Director, Federal-Provincial Relations and Social Policy Branch
Barbara Anderson, Director, Federal-Provincial Relations Division - Federal-Provincial Relations and Social Policy Branch

Thursday, September 21, 2000

As an individual:
Graham Scott, Former Deputy Minister of Health, Province of Ontario


OTHER WRITTEN SUBMISSIONS RECEIVED:

Abell Medical Clinic
Alberta Centre for Injury Control and Research
Amgen Canada Inc.
Ancaster-Dundas-Flamborough-Aldershot New Democratic Party Riding Association Executive Committee
Association of Canadian Medical Colleges (ACMC)
Patricia Baird
B.C. Better Care Pharmacare Coalition
Bruce Bigham
Brain Injury Association of Nova Scotia
Robert D. Brown and Michanne Haynes
Canada Health Infoway
Canada's Research-Based Pharmaceutical Companies
Canada West Foundation
Canadian Association of Emergency Physicians (CAEP)
Canadian Association of Internes and Residents
Canadian Blood Services
Canadian Caregiver Coalition
Canadian Cochrane Network and Centre
Canadian Council on Integrated Healthcare
Canadian Dental Hygienists Association
Canadian Drug Manufacturers Association (CDMA)
Canadian Strategy for Cancer Control
Cancer Care Ontario, Division of Preventive Oncology
Chemical Sensitivities Information Exchange Network Manitoba (CSIENM)
Conestoga College (Pat Bower, Course instructor)
Laurent Desjardins
Faith Partners (Ottawa)
Federation of Medical Women in Canada
Sandra Finley
Dr. Michael Gordon, Baycrest Centre for Geriatric Care
Serena Grant
Health Care Corporation of St.John's
Heart and Stroke Foundation of New Brunswick
Home-based Spiritual Care
Kidney Foundation of Canada
Kids First Parent Association of Canada 
Dr. Lee Kurisko
Caterine Lindman
Jim Ludwig
Dr. Keith Martin 
Dr. Ross McElroy
Dr. Malcom S. McPhee
Meals on Wheels of Calgary
Medbuy Corporation
Verna Milligan
Moose Jaw-Thunder Creek District Health Board
Dr. Earl B. Morris
Fran Morrison
Multiple Sclerosis Society of Canada
John Neilson
Ontario Chamber of Commerce
Ontario Psychological Association
Roy L. Piepenburg (Liberation Consulting)
Red Deer Network in Support of Medicare
Dr. Robert S. Russell
Society of Obstetricians and Gynaecologists of Canada
Christa Streicher
Thames Valley District Health Council
Elaine Tostevin
University of Ottawa Heart Institute
University of Ottawa Institute of Population Health (Dr. Joseph Losos, Director)


Back to top